Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-11 Option Award | 2022-03-14 7:58 pm | N/A 2032-03-11 | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2021-07-30 Exercise | 2021-08-05 7:55 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 53,672 | $2.95 | 201,762 (Direct) | View |
| 2021-07-30 Exercise | 2021-08-05 7:55 pm | N/A 2029-12-04 | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 53,672 | $0 | 201,762 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-25 8:00 pm | N/A 2031-06-24 | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 72,000 | $0 | 72,000 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:15 pm | N/A 2031-03-01 | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 72,000 | $0 | 72,000 (Direct) | View |
| 2020-07-23 Ownership | 2020-07-23 7:21 pm | N/A 2029-12-04 | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 0 | $0 | 365,671 (Direct) | View |